{"id":54272,"date":"2023-02-27T17:04:15","date_gmt":"2023-02-27T16:04:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/"},"modified":"2023-02-27T17:04:15","modified_gmt":"2023-02-27T16:04:15","slug":"egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/","title":{"rendered":"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease"},"content":{"rendered":"
\n

\nPartnership leverages egnite\u2019s artificial intelligence and big data expertise with Philippe G\u00e9n\u00e9reux and Linda Gillam from Morristown\u2019s world-class Gagnon Cardiovascular Institute<\/i><\/strong>\n<\/p>\n

ALISO VIEJO, Calif.–(BUSINESS WIRE)–#digitalhealth<\/a>—egnite<\/a>, a digital healthcare company, announces a partnership with leading physicians from Morristown\u2019s Gagnon Cardiovascular Institute, Philippe G\u00e9n\u00e9reux, a Director of the Structural Heart Program, and Linda Gillam, Chair of Cardiovascular Medicine. This partnership aims to elevate the standard of care for patients with cardiovascular (CV) disease, which affects an estimated 126 million adults in the U.S.i<\/sup> and is expected to increase by 30% by 2060ii<\/sup>.\n<\/p>\n

<\/a><\/p>\n

\nThe partnership will spearhead research initiatives to better understand optimal points of therapeutic intervention for patients with valvular heart disease, using egnite\u2019s flagship digital health platform, CardioCare. This initiative furthers the use of precision medicine algorithms to help physicians design and deliver an individualized patient management plan.\n<\/p>\n

\n\u201cCardioCare\u2019s AI tools will help us ensure that every patient receives optimal evaluation and management of their heart disease,\u201d says Gillam, adding, \u201cIts big data approach will also help us identify patients who might be candidates for one of many research trials, thereby potentially giving patients access to otherwise unavailable therapeutic options.\u201d\n<\/p>\n

\n\u201cWe are honored to be partnering with Doctors Gillam and G\u00e9n\u00e9reux, and working with physicians of this caliber will help us accelerate our platform\u2019s innovation,\u201d said Joel Portice, president and CEO of egnite.\n<\/p>\n

\nThe partnership will also support the expansion of Dr. G\u00e9n\u00e9reux\u2019s staging research, which examines the value of cardiac staging relating to the treatment and outcomes of AS & MR using the 12 million de-identified cardiovascular encounters in egnite\u2019s database.\n<\/p>\n

\n\u201cI am thrilled to collaborate with egnite\u2019s team and use their incredible platform to better understand valve disease, build meaningful research, and improve patient management and outcomes,\u201d said G\u00e9n\u00e9reux.\n<\/p>\n

\nAbout egnite, Inc.<\/b>\n<\/p>\n

\negnite is a visionary digital health company committed to advancing the health of our society through innovative cardiovascular solutions. egnite uses AI-driven algorithms and big data to produce business intelligence for healthcare, elevating the role of data in critical decisions. The company partners with leading hospitals and life sciences organizations to transform care delivery for cardiovascular patients. The company is based in Aliso Viejo, Calif., for more information, visit www.egnitehealth.com<\/a>.\n<\/p>\n

\negnite, egnite, Inc., the spark logo, and CardioCare are trademarks of egnite, Inc. All other trademarks are the property of their respective owners.\n<\/p>\n

\n______________\n<\/p>\n

\ni<\/sup> Virani SS, Alonso A, Aparicio HJ, et al.; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association. Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161\/CIR.0000000000000950\n<\/p>\n

\nii<\/sup> Reza Mohebi, Chen Chen, Nasrien E. Ibrahim, et al. Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. J Am Coll Cardiol. 2022 Aug, 80 (6) 565\u2013578.<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTorrey Loper
\n
egnite
\n
480-467-8685
\n
Torrey.loper@egnitehealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Partnership leverages egnite\u2019s artificial intelligence and big data expertise with Philippe G\u00e9n\u00e9reux and Linda Gillam from Morristown\u2019s world-class Gagnon Cardiovascular Institute ALISO VIEJO, Calif.–(BUSINESS WIRE)–#digitalhealth—egnite, a digital healthcare company, announces a partnership with leading physicians from Morristown\u2019s Gagnon Cardiovascular Institute, Philippe G\u00e9n\u00e9reux, a Director of the Structural Heart Program, and Linda Gillam, Chair of Cardiovascular … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54272","6":"format-standard","7":"category-industry"},"yoast_head":"\negnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Partnership leverages egnite\u2019s artificial intelligence and big data expertise with Philippe G\u00e9n\u00e9reux and Linda Gillam from Morristown\u2019s world-class Gagnon Cardiovascular Institute ALISO VIEJO, Calif.–(BUSINESS WIRE)–#digitalhealth—egnite, a digital healthcare company, announces a partnership with leading physicians from Morristown\u2019s Gagnon Cardiovascular Institute, Philippe G\u00e9n\u00e9reux, a Director of the Structural Heart Program, and Linda Gillam, Chair of Cardiovascular ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-27T16:04:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230227005120\/en\/1722732\/21\/Egnite_Main_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease\",\"datePublished\":\"2023-02-27T16:04:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/\"},\"wordCount\":513,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005120\\\/en\\\/1722732\\\/21\\\/Egnite_Main_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/\",\"name\":\"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005120\\\/en\\\/1722732\\\/21\\\/Egnite_Main_Logo.jpg\",\"datePublished\":\"2023-02-27T16:04:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005120\\\/en\\\/1722732\\\/21\\\/Egnite_Main_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005120\\\/en\\\/1722732\\\/21\\\/Egnite_Main_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/","og_locale":"en_US","og_type":"article","og_title":"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease - Pharma Trend","og_description":"Partnership leverages egnite\u2019s artificial intelligence and big data expertise with Philippe G\u00e9n\u00e9reux and Linda Gillam from Morristown\u2019s world-class Gagnon Cardiovascular Institute ALISO VIEJO, Calif.–(BUSINESS WIRE)–#digitalhealth—egnite, a digital healthcare company, announces a partnership with leading physicians from Morristown\u2019s Gagnon Cardiovascular Institute, Philippe G\u00e9n\u00e9reux, a Director of the Structural Heart Program, and Linda Gillam, Chair of Cardiovascular ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-27T16:04:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230227005120\/en\/1722732\/21\/Egnite_Main_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease","datePublished":"2023-02-27T16:04:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/"},"wordCount":513,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230227005120\/en\/1722732\/21\/Egnite_Main_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/","url":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/","name":"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230227005120\/en\/1722732\/21\/Egnite_Main_Logo.jpg","datePublished":"2023-02-27T16:04:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230227005120\/en\/1722732\/21\/Egnite_Main_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230227005120\/en\/1722732\/21\/Egnite_Main_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/egnite-inc-announces-a-i-partnership-with-leading-physicians-to-elevate-the-standard-of-care-for-patients-with-cardiovascular-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54272"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54272\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}